Share

Publications & Documents


  • 19-November-2020

    English

    Health at a Glance: Europe 2020 - State of Health in the EU Cycle

    The 2020 edition of Health at a Glance: Europe focuses on the impact of the COVID‑19 crisis. Chapter 1 provides an initial assessment of the resilience of European health systems to the COVID-19 pandemic and their ability to contain and respond to the worst pandemic in the past century. Chapter 2 reviews the huge health and welfare burden of air pollution as another major public health issue in European countries, and highlights the need for sustained efforts to reduce air pollution to mitigate its impact on health and mortality. The five other chapters provide an overview of key indicators of health and health systems across the 27 EU member states, 5 EU candidate countries, 3 European Free Trade Association countries and the United Kingdom. Health at a Glance: Europe is the first step in the State of Health in the EU cycle.
  • 19-November-2020

    English

    Europe needs to prepare better for coming out of new strict containment measures

    With the coronavirus (COVID-19) once again spreading rapidly, and the re-introduction of containment measures to flatten the curve of the epidemic, it is crucial for policymakers to plan effective strategies to re-open their economies to avoid further re-confinements.

    Related Documents
  • 17-November-2020

    English

    Antimicrobial Resistance

    Antimicrobial resistance (AMR) is a complex issue of global concern with potentially dramatic health and economic consequences. The OECD provides a forum for discussion and provide countries with the evidence to implement effective and cost-effective policies to tackle AMR, promote effective use of antimicrobials and incentivise research and development in the antibiotic sector.

  • 13-November-2020

    English

    Challenges in access to oncology medicines - Policies and practices across the OECD and the EU

    With rapid advancements in oncology, even the wealthiest countries around the globe find it increasingly challenging to provide – and sustain – access to new medicines. Challenges include managing the uncertainty surrounding the extent of benefit of new treatments; complexities in determining the price and place in therapy of certain products; and the need to reconcile affordable, equitable access with spending efficiency and fiscal sustainability. Differences in timing of market entry and heterogeneity of coverage processes and policies contribute to inequity in access across the OECD and EU. Future policies and practices to promote sustainable access to oncology medicines will likely focus on improving affordability for patients and value-for-money for payers. An important element will be strengthening the evidence base, drawing on both clinical trial and 'real world' evidence, and enhancing international collaboration and information sharing to improve countries’ collective capacity to address clinical and economic uncertainties.
  • 3-November-2020

    English

    Key nanotechnology indicators

    Indicators include nanotech firms, nanotech R&D, public sector R&D expenditure and nanotechnology patents.

    Related Documents
  • 3-November-2020

    English

    Key biotechnology indicators

    Statistics on biotechnology firms, biotechnology R&D (including public sector expenditures), biotech applications and patents.

  • 20-October-2020

    English

    Health Inequalities

    Despite remarkable progress in health status and life expectancy in OECD countries over the past decades, there remain large inequalities not only across countries, but also across population groups within each country. These inequalities in health status are linked to many factors, including differences in exposure to risk factors to health and in access to health care.

  • 20-October-2020

    English

    Mental Health and Work

    Mental illness is a growing problem in society and is increasingly affecting productivity and well-being in the workplace. This project challenges some of the myths around mental health.

    Related Documents
    Also AvailableEgalement disponible(s)
  • 20-October-2020

    English

    Health Systems Characteristics

    Responses from the OECD Health System Characteristics Survey are available online, providing access to the most recent information on key institutional characteristics of health systems of OECD countries, key partner and accession countries for its 2012 and 2016 editions, as well as Latin American and Caribbean (LAC) countries for its 2018 edition.

    Related Documents
  • 20-October-2020

    English

    Paying providers for health care

    How health providers are paid is one of the key policy levers that countries have to drive health system performance. The 2012 HSC Survey analyses the payment modes currently in use in OECD countries to remunerate primary care, outpatient specialist care and inpatient care, the price regulations for health services and identifies new innovative modes of payments in more detail.

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 > >>